Purpose of Review
Several studies have demonstrated the benefits of glycemic control in the perioperative period and there is ongoing interest in development of systematic approaches to achieving glycemic control. This review discusses currently available data and proposes a new approach to the management of hyperglycemia in the perioperative period.
In a recent study, we demonstrated that early preoperative identification of patients with poorly controlled diabetes and proactive treatment through various phases of surgery improves glycemic control, lowers the risk of surgical complications, and decreases the length of hospital stay.
Implementation of a perioperative diabetes program that systematically identifies and treats patients with poor glycemic control early in the preoperative period is feasible and improves clinical care of patients undergoing elective surgery.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Garg R, Grover A, McGurk S, Rawn JD. Predictors of hyperglycemia after cardiac surgery in nondiabetic patients. J Thorac Cardiovasc Surg. 2013;145(4):1083–7. https://doi.org/10.1016/j.jtcvs.2012.07.089.
King JT Jr, Goulet JL, Perkal MF, Rosenthal RA. Glycemic control and infections in patients with diabetes undergoing noncardiac surgery. Ann Surg. 2011;253(1):158–65. https://doi.org/10.1097/SLA.0b013e3181f9bb3a.
Mraovic B, Hipszer BR, Epstein RH, Pequignot EC, Parvizi J, Joseph JI. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplast. 2010;25(1):64–70. https://doi.org/10.1016/j.arth.2008.10.002.
Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33(8):1783–8. https://doi.org/10.2337/dc10-0304.
Buehler L, Fayfman M, Alexopoulos AS, Zhao L, Farrokhi F, Weaver J, et al. The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients. J Diabetes Complicat. 2015;29(8):1177–82. https://doi.org/10.1016/j.jdiacomp.2015.07.027.
Lilienfeld DE, Vlahov D, Tenney JH, McLaughlin JS. Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Control. 1988;16(1):3–6.
Garg R, Tripathy D, Dandona P. Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions. Curr Drug Targets. 2003;4(6):487–92.
Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med. 1995;123(12):919–24.
Rassias AJ, Marrin CA, Arruda J, Whalen PK, Beach M, Yeager MP. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg. 1999;88(5):1011–6.
Saito Y, Takahashi I, Iwane K, Okubo N, Nishimura M, Matsuzaka M, et al. The influence of blood glucose on neutrophil function in individuals without diabetes. Luminescence. 2013;28(4):569–73. https://doi.org/10.1002/bio.2495.
Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106(16):2067–72.
Dandona P, Aljada A, Dhindsa S, Garg R. Insulin as an anti-inflammatory and antiatherosclerotic hormone. Clin Cornerstone. 2003;Suppl 4:S13–20. https://doi.org/10.1016/S1098-3597(03)90062-7.
Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol. 2007;99(4A):15B–26B. https://doi.org/10.1016/j.amjcard.2006.11.003.
Dandona P, Aljada A, Chaudhuri A, Mohanty P. Endothelial dysfunction, inflammation and diabetes. Rev Endocr Metab Disord. 2004;5(3):189–97. https://doi.org/10.1023/B:REMD.0000032407.88070.0a.
Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40(3):418–23.
Szabo Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2002;74(3):712–9.
Ramos M, Khalpey Z, Lipsitz S, Steinberg J, Panizales MT, Zinner M, et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg. 2008;248(4):585–91. https://doi.org/10.1097/SLA.0b013e31818990d1.
Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;91(7):1621–9. https://doi.org/10.2106/JBJS.H.00116.
• Sathya B, Davis R, Taveira T, Whitlatch H, Wu WC. Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract. 2013;102(1):8–15. https://doi.org/10.1016/j.diabres.2013.05.003. This study highlights the correlation of glucose levels with postoperative outcomes and suggests perioperative glycemic targets.
Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67(2):352–60 discussion 60-2.
Furnary AP, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endocr Pract. 2006;12(Suppl 3):22–6. https://doi.org/10.4158/ep.12.S3.22.
Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109(12):1497–502. https://doi.org/10.1161/01.CIR.0000121747.71054.79.
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med. 2001;345(19):1359–67.
Jamsen E, Nevalainen P, Kalliovalkama J, Moilanen T. Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med. 2010;21(3):196–201. https://doi.org/10.1016/j.ejim.2010.02.006.
Offodile AC II, Chou HY, Lin JA, Loh CYY, Chang KP, Aycart MA, et al. Hyperglycemia and risk of adverse outcomes following microvascular reconstruction of oncologic head and neck defects. Oral Oncol. 2018;79:15–9. https://doi.org/10.1016/j.oraloncology.2018.02.009.
Gachabayov M, Senagore AJ, Abbas SK, Yelika SB, You K, Bergamaschi R. Perioperative hyperglycemia: an unmet need within a surgical site infection bundle. Tech Coloproctol. 2018;22(3):201–7. https://doi.org/10.1007/s10151-018-1769-2.
Yong PH, Weinberg L, Torkamani N, Churilov L, Robbins RJ, Ma R, et al. The presence of diabetes and higher HbA1c are independently associated with adverse outcomes after surgery. Diabetes Care. 2018;41:1172–9. https://doi.org/10.2337/dc17-2304.
• Underwood P, Askari R, Hurwitz S, Chamarthi B, Garg R. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014;37(3):611–6. https://doi.org/10.2337/dc13-1929. This study shows that HbA1c > 8% is associated with long hospital stay in patients undergoing a non-cardiac surgery. Therefore, HbA1c 8% is a good threshold for glycemic control before surgery.
O’Sullivan CJ, Hynes N, Mahendran B, Andrews EJ, Avalos G, Tawfik S, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006;32(2):188–97. https://doi.org/10.1016/j.ejvs.2006.01.011.
Halkos ME, Puskas JD, Lattouf OM, Kilgo P, Kerendi F, Song HK, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008;136(3):631–40. https://doi.org/10.1016/j.jtcvs.2008.02.091.
Godshaw BM, Ojard CA, Adams TM, Chimento GF, Mohammed A, Waddell BS. Preoperative glycemic control predicts perioperative serum glucose levels in patients undergoing Total joint arthroplasty. J Arthroplast. 2018;33(7s):S76–s80. https://doi.org/10.1016/j.arth.2018.02.071.
Jehan F, Khan M, Sakran JV, Khreiss M, O’Keeffe T, Chi A, et al. Perioperative glycemic control and postoperative complications in patients undergoing emergency general surgery: what is the role of plasma hemoglobin A1c? J Trauma Acute Care Surg. 2018;84(1):112–7. https://doi.org/10.1097/TA.0000000000001724.
Yang L, Sun Y, Li G, Liu J. Is hemoglobin A1c and perioperative hyperglycemia predictive of periprosthetic joint infection following total joint arthroplasty?: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(51):e8805. https://doi.org/10.1097/MD.0000000000008805.
Steely AM, Smith L, Callas PW, Nathan MH, Lahiri JE, Stanley AC, et al. Prospective study of postoperative glycemic control with a standardized insulin infusion protocol after infrainguinal bypass and open abdominal aortic aneurysm repair. Ann Vasc Surg. 2017. https://doi.org/10.1016/j.avsg.2017.04.020.
Lamos EM, Wijesinha MA, Ramhmdani S, Magder LS, Silver KD. Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation. Diabetes Metab Syndr Obes. 2017;10:13–7. https://doi.org/10.2147/DMSO.S118437.
Cheisson G, Jacqueminet S, Cosson E, Ichai C, Leguerrier AM, Nicolescu-Catargi B, et al. Perioperative management of adult diabetic patients. Intraoperative period. Anaesth Crit Care Pain Med. 2018;37 Suppl 1:S21–s5. https://doi.org/10.1016/j.accpm.2018.02.018.
•• Dhatariya K, Levy N, Kilvert A, Watson B, Cousins D, Flanagan D, et al. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012;29(4):420–33. https://doi.org/10.1111/j.1464-5491.2012.03582.x. This paper is British guidelines for the perioperative management of diabetes.
American Diabetes A. Diabetes care in the hospital: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S144–S51. https://doi.org/10.2337/dc18-S014.
•• Underwood P, Seiden J, Carbone K, Chamarthi B, Turchin A, Bader AM, et al. Early identification of individuals with poorly controlled diabetes undergoing elective surgery: improving A1C testing in the preoperative period. Endocr Pract. 2015;21(3):231–6. https://doi.org/10.4158/EP14228.OR. This study describes the process of implementation of a preoperative program for HbA1c testing and the outcomes of this program.
Perna M, Romagnuolo J, Morgan K, Byrne TK, Baker M. Preoperative hemoglobin A1c and postoperative glucose control in outcomes after gastric bypass for obesity. Surg Obes Relat Dis. 2012;8(6):685–90. https://doi.org/10.1016/j.soard.2011.08.002.
• Garg R, Metzger C, Rein R, Lortie M, Underwood P, Hurwitz S, et al. Nurse practitioner-mediated intervention for preoperative control of diabetes in elective surgery patients. J Am Assoc Nurse Pract. 2016;28(10):528–33. https://doi.org/10.1002/2327-6924.12365. This study showed that non-physician providers can improve the implementation of a perioperative diabetes program.
•• Garg R, Schuman B, Bader A, Hurwitz S, Turchin A, Underwood P, et al. Effect of preoperative diabetes management on glycemic control and clinical outcomes after elective surgery. Ann Surg. 2018;267(5):858–62. https://doi.org/10.1097/SLA.0000000000002323. This study showed that a systematic identification of patients with poorly controlled diabetes and their proactive treatment can improve glycemic control and decrease length of hospital stay.
Kielhorn BA, Senagore AJ, Asgeirsson T. The benefits of a low dose complex carbohydrate/citrulline electrolyte solution for preoperative carbohydrate loading: focus on glycemic variability. Am J Surg. 2018;215(3):373–6. https://doi.org/10.1016/j.amjsurg.2017.10.029.
Rushakoff RJ, Wick EC, McDonnell ME. Enhanced recovery in patients with diabetes: is it time for a moratorium on use of preoperative carbohydrate beverages? Ann Surg. 2018. https://doi.org/10.1097/sla.0000000000002989.
Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146(4):233–43.
American Diabetes Association. Diabetes care in the hospital. Diabetes Care. 2016;39(Supplement 1):S99–S104. https://doi.org/10.2337/dc16-S016.
Aggarwal A, Rawn JD, Pendergrass ML, Garg RK. Long-acting subcutaneously administered insulin for glycemic control immediately after cardiac surgery. Endocr Pract. 2011;17(4):558–62. https://doi.org/10.4158/ep10354.Or.
Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2):256–61. https://doi.org/10.2337/dc10-1407.
Garg R, Schuman B, Hurwitz S, Metzger C, Bhandari S. Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients. BMJ Open Diabetes Res Care. 2017;5(1):e000394. https://doi.org/10.1136/bmjdrc-2017-000394.
Fayfman M, Davis G, Duggan EW, Urrutia M, Chachkhiani D, Schindler J, et al. Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: a pilot randomized study. J Diabetes Complicat. 2018;32:1091–6. https://doi.org/10.1016/j.jdiacomp.2018.08.014.
Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, Gomez PC, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diab Endocrinol. 2017;5(2):125–33. https://doi.org/10.1016/s2213-8587(16)30402-8.
Garg R, Jarry A, Pendergrass M. Delay in blood glucose monitoring during an insulin infusion protocol is associated with increased risk of hypoglycemia in intensive care units. J Hosp Med. 2009;4(6):E5–7. https://doi.org/10.1002/jhm.436.
Garg R, Hurwitz S, Turchin A, Trivedi A. Hypoglycemia, with or without insulin therapy, is associated with increased mortality among hospitalized patients. Diabetes Care. 2013;36(5):1107–10. https://doi.org/10.2337/dc12-1296.
Simha V, Shah P. Perioperative glucose control in patients with diabetes undergoing elective surgery. JAMA. 2019;321:399. https://doi.org/10.1001/jama.2018.20922.
Conflict of Interest
The authors declare that they have no conflict of interest. Many studies performed by the authors are cited in the text.
Human and Animal Right and Informed Consent
This is a review article and it did not involve conducting studies with humans or animals.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Health Care Delivery Systems and Implementation in Diabetes
About this article
Cite this article
Palermo, N.E., Garg, R. Perioperative Management of Diabetes Mellitus: Novel Approaches. Curr Diab Rep 19, 14 (2019). https://doi.org/10.1007/s11892-019-1132-7
- Diabetes mellitus
- Surgery outcomes
- Perioperative treatment
- Stress hyperglycemia